Piroxicam Versus Diclofenac for Post Caesarean Section Analgesia

NCT06943092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2025-04-24

No results posted yet for this study

Summary

Multimodal analgesic combination of pentazocine-diclofenac has been found to be superior to pentazocine-piroxicam and was associated with a higher level of maternal satisfaction. our study aims to determine the efficacy of piroxicam when compared with diclofenac as pain relief post caesarean section.

Conditions

  • Analgesia
  • Post Caserean

Interventions

DRUG

Piroxicam group

Experimental drug

DRUG

Diclofenac group

Active drug

Sponsors & Collaborators

  • Federal Teaching Hospital Abakaliki

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-11
Primary Completion
2020-06-08
Completion
2020-06-08

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06943092 on ClinicalTrials.gov